From August 30, 2023 to August 30, 2023, the company has repurchased 124,764 shares, representing 0.61% for KRW 299.43 million. With this, the company has completed the repurchase of 124,764 shares, representing 0.61% for KRW 299.43 million under the buyback announced on August 30, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,799 KRW | -2.02% | -3.80% | -29.86% |
1st Jan change | Capi. | |
---|---|---|
-29.86% | 42.88M | |
+1.51% | 42.75B | |
+47.70% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- A352770 Stock
- News Clinomics Inc.
- Tranche Update on Clinomics Inc.'s Equity Buyback Plan announced on August 30, 2023.